191 related articles for article (PubMed ID: 11434573)
1. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
2. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
4. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis and the risk of malignancy.
Cibere J; Sibley J; Haga M
Arthritis Rheum; 1997 Sep; 40(9):1580-6. PubMed ID: 9324011
[TBL] [Abstract][Full Text] [Related]
6. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
9. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
10. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of malignancy in patients with systemic lupus erythematosus.
Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
14. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies.
Apor E; O'Brien J; Stephen M; Castillo JJ
Leuk Res; 2014 Sep; 38(9):1067-71. PubMed ID: 25052307
[TBL] [Abstract][Full Text] [Related]
16. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
18. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
19. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
Tallbacka KR; Pettersson T; Pukkala E
Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]